NSC |
Compound |
Enrichment |
Correlation |
NSC 736164 |
pyrazoline derivative |
0.0228801759885687 |
0.055512116 |
NSC 740276 |
5,6-Dihydro-6-[3-(hydroxyethyl)amino-1-propyl]-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Hydrochloide |
0.0228801759885687 |
0.33312533 |
NSC 743862 |
Null |
0.0228801759885687 |
0.077393924 |
NSC 744331 |
(2R,11aS)-8- {2-[4-(2-{[(2R,11aS)-C2-di-Fluoro-7-Methoxy-5-oxo-2,3,5,11a-tetrahydro-1-H-benzo[e]-pyrrolo[1,2-a][1,4]diazepine-8-yl}propyl)piperazino]propoxy}-C2-di-fluoro-7-Methoxy-2,3,5,11a-tetrahyd |
0.0228801759885687 |
0.14756036 |
NSC 756166 |
GSK312948A |
0.0228801759885687 |
0.16002123 |
NSC 89822 |
Null |
0.0228801759885687 |
0.25855338 |
NSC 205555 |
Butanoic acid, 2,3-dibromo-4-[(5-chloro-2-methoxyphenyl)amino]-4-oxo- |
0.0228801759885691 |
-0.083971004 |
NSC 237020 |
TA 1067 |
0.0228801759885691 |
0.49283371 |
NSC 281817 |
Ethanol, 2,2'-[[4-[[[4-[2-(4-bromophenyl)-4-thiazolyl]phenyl]imino]methyl]-3-methylphenyl]imino]bis-, dimethanesulfonate (ester) |
0.0228801759885691 |
0.50690047 |
NSC 301739 |
Mitoxantrone |
0.0228801759885691 |
0.34591614 |